Megan Ivory has been named director of federal government relations for the medical device industry association AdvaMed (Washington). Previously, Ivory served as a senior legislative assistant for Rep. Jim Ramstad (R-Minnesota).
Adele Gulfo has been appointed vice president, U.S. cardiovascular therapeutic area, for AstraZeneca (Wayne, Pennsylvania). Previously, Gulfo was senior director, cardiovascular marketing, for Parke-Davis.
Patrick Bradley, PhD, has been named vice president of business development at CardioDynamics International (San Diego, California), maker of the BioZ noninvasive digital cardiac function monitoring systems. Bradley most recently worked at Cardiac Science. CardioDynamics is a medical technology and information solutions company focused on hemodynamic monitoring.
John Warner, PhD, has been promoted from vice president of technology to vice president of technology and research for Collateral Therapeutics (San Diego, California). The promotion gives him responsibility for overseeing the expansion of the company's research facilities in San Diego, California. Prior to joining Collateral in May, Warner was vice president, research, at Valentis. Collateral develops non-surgical gene therapy products for the treatment of cardiovascular diseases.
Percardia (Boston, Massachusetts) has named Laurence Roth vice president of development and Jill Wollins, PhD, vice president of regulatory affairs and quality assurance. Roth was previously employed at Focal. Wollins was formerly with Agilent Technologies. Percardia is a privately held medical device company developing therapeutic interventions for coronary artery disease.
Eapen Chacko has been promoted to the new post of vice president of finance and chief financial officer at Possis Medical (Minneapolis, Minnesota). Chacko had been serving as vice president of investor and public relations. Possis makes medical devices for the cardiovascular and vascular treatment markets.
Glenn Foley has been appointed president and chief executive officer of Precision Vascular Systems (PVS; Salt Lake City, Utah). Foley also will join PVS's board of directors. Prior to joining the company, Foley was vice president, global sales, for Medtronic Vascular. PVS develops vascular access and other therapeutic devices.
John Bergeron has been named vice president and corporate treasurer at Zoll Medical (Burlington, Massachusetts). Most recently, Bergeron was vice president of Ionics. Zoll makes non-invasive cardiac resuscitation devices and disposable electrodes.